Education
About Us
Working with TipRanks
Follow Us
Scancell Holdings PLC (GB:SCLP)
LSE:SCLP
Pembrolizumab, Modi-1 Moditope, Micronjet600™ Microneedle Device (Nanopass)
Triple Negative Breast Cancer, Squamous Cell Carcinoma Of The Head And Neck, Renal Cell Cancer, High Grade Ovarian Serous Adenocarcinoma
Phase I/II
Recruiting
Modi-1 Moditope in Breast, Head and Neck, Ovarian, or Renal Cancer
Jan 31, 2022
―
Scib1 Or Iscib1+ Dna Vaccine
Malignant Melanoma, Melanoma Stage Iii, Melanoma Stage Iv, Melanoma (Skin)
Phase II
Recruiting
SCIB1 and iSCIB1+ in Melanoma Patients Receiving Nivolumab With Ipilimumab or SCIB1 With Pembrolizumab (The SCOPE Study)
Aug 16, 2019
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Scancell Holdings PLC (SCLP) have in its pipeline
SCLP is currently developing the following drugs: Pembrolizumab, Modi-1 Moditope, Micronjet600™ Microneedle Device (Nanopass), Scib1 Or Iscib1+ Dna Vaccine. These drug candidates are in various stages of clinical development as the company works toward FDA approval.